
Ogen S.A. in liquidation
KRS: NIP: REGON:
Overview
Status
Deleted
Activity period
2019-01-17 – 2026-09-21
Share capital
109,979.60 PLN
Activity description
Ogen offers individual genetic tests based on a saliva sample collected at home. The reports cover predispositions related to diet, sports, beauty, health, medication metabolism, immunity, and sleep and stress; results are available after several weeks, with prices starting at PLN 599.
Registered address
ul. Tomasza Nocznickiego 31, 01-918 Warszawa, Poland
Electronic delivery address
AE:PL-29194-95870-SAISW-23
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. W związku z ujemnym kapitałem, Zarząd z dniem 27.04.2025 podjął decyzję o likwidacji spółki.
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Mazowieckie94,290 / 142,258
Top 66%
Country · Poland339,042 / 496,593
Top 68%
Results vs voivodeship
Revenue
This companyUSD 47.44kMedianUSD 156.09kAverageUSD 5.54m
Net profit
This companyUSD 18.47kMedianUSD 2.44kAverageUSD 281.33k
Operating costs
This companyUSD 18.60kMedianUSD 131.24kAverageUSD 4.70m
Assets
This companyUSD 11.61kMedianUSD 162.74kAverageUSD 11.15m
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
16 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Jul 23, 2026 | Shareholders' meeting convened | |
| Oct 28, 2025 | Shareholders' meeting convened | |
| Jun 11, 2025 | Call to creditors | |
| May 27, 2025 | Liquidation opened | |
| Apr 4, 2025 | Shareholders' meeting convened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-21 | Struck off the register | |
| 2026-08-17 | Liquidation ended / withdrawn | |
| 2025-05-09 | Name change (Ogen → Ogen Spółka Akcyjna W Likwidacji) | |
| 2025-04-28 | Liquidation opened | |
| 2023-01-20 | Share capital increase (107,482.00 PLN → 109,979.60 PLN) |
FAQ
The company was registered in the Polish National Court Register (KRS) on January 17, 2019.
The headquarters is located at: ul. Tomasza Nocznickiego 31, 01-918 Warszawa.
The share capital of the company is PLN 109,980 (approx. $29,708).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 47,443, representing an increase of 215.5% compared to 2024.
Yes, the company recorded a net profit of USD 18,469 in 2025.
The largest operating cost category falls under external services. This category amounted to USD 9,256 in 2025, representing 50% of all operating expenses.
Last updated: 2026-10-03